Apoptosis and cytologic differentiation in hepatocellular carcinoma on fine needle aspiration samples

Acta Cytologica

Volumn 40, Issue 5, 1996, Pages 861-866

  Zeppa, Pio ^a,b,c   Benincasa, Giulio ^a,b,c   Fulciniti, Franco ^a,b,c   Cochand Priollet, Beatrix ^a,b,c,d   Troncone, Giancarlo ^a,b,c   Vetrani, Antonio ^a,b,c   Celentano, Egidio ^a,b,c   Nardone, Gerardo ^a,b,c   Palombini, Lucio ^a,b,c  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Epidemiology and Prevention Department   (Italy)

^c HÔPITAL LARIBOISIÈRE   (France)

^d Service d Anatomie Pathologique   (Italy)

Author keywords

Apoptosis; Bcl 2 protein; Hepatocellular carcinoma; Needle biopsy

Indexed keywords

PROTEIN BCL 2;

APOPTOSIS; ARTICLE; ASPIRATION BIOPSY; CANCER CYTODIAGNOSIS; CELL DIFFERENTIATION; HUMAN; IMMUNOCYTOCHEMISTRY; IMMUNOPEROXIDASE STAINING; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0029746170     PISSN: 00015547     EISSN: 19382650     Source Type: Journal    
DOI: 10.1159/000333992     Document Type: Article

References (30)

1. Bhagava V, Kell DL, van de Rijn M, Warnke RA: bcl-2 Im-munoreactivity in breast carcinoma correlates with hormone receptor positivity. Am J Pathol 1994;145:535-540
2. Brada M: bcl-2 Gene: Current relevance to clinical oncology. Eur J Cancer 1992;28:270-277
3. Brown DC, Gatter KC, Dunnill MS, Mason DY: Immunocy-tochemical analysis of cytocentrifuged fine-needle aspirates: A study based on lung tumors aspirated in vitro. Analyt Quant Cytol Histol 1989;11:140-145
4. Charlotte F, L'hermine A, Martin N, Geleyn Y, Nollet M, Gaulard P, Zafrani ES: Immunohistochemical detection of bcl-2 protein in normal and pathological human liver. Am J Pathol 1994;144:460-465
5. Colombel M, Symmans F, Gil S, O'toole KM, Chopin D, Benson M, Olsson CA, Korsmeyer S, Buttyan R: Detection of the apoptosis-suppressing oncoprotein bcl-2 in hormone-refractory human prostate cancers. Am J Pathol 1993;143: 390-400
6. Cottier M, Jouffre C, Maubon I, Sabibo O, Barthelemy C, Cuilleron M, Veyret C, Laurent JL, Audigier JC: Prospective flow cytometric DNA analysis of hepatocellular carcinoma specimens collected by ultrasound-guided fine needle aspiration. Cancer 1994;74:599-605
7. Gompel A, Sabourin JC, Martin A, Yaneva H, Audouin J, De-croix Y, Poitout P: bcl-2 Expression in normal endometrium during the menstrual cycle. Am J Pathol 1994;144:1195-1202
8. Hockenbery DM, Zutter M, Hickey W: bcl-2 Protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA 1991;88:6961-6965
9. Irene OLNG, Lai ECS, Fan ST, Mattew LNG: Prognostic significance of proliferating cell nuclear antigen expression in hepatocellular carcinoma. Cancer 1994;73:2268-2274
10. Kitamoto M, Nakanishi T, Kira S, Kawaguchi M, Nakashio R, Suemori S, Kajiyama G, Asahara T, Dohi K: The assessment of proliferating cell nuclear antigen immunohisto-chemical staining in small hepatocellular carcinoma and its relationship to histologic characteristics and prognosis. Cancer 1993;72:1859-1864
11. Nadji M, Ganjei P: Immunocytochemistry in diagnostic cytology: A 12-year perspective. Am J Clin Pathol 1990;94:470-475
12. Nagao T, Kondo Y, Sato T, Nagato Y, Kondo Y: Immunohis-tochemical detection of aberrant p53 expression in hepatocellular carcinoma: Correlation with cell proliferative activity indices, including mitotic index and MIB-1 immu-nostaining. Hum Pathol 1995;26:326-332
13. Ojanguren I, Ariza A, Castellá EM, Fernández-Vasalo A, Mate JL, Navas-Palacios JJ: p53 Immunoreactivity in hepatocellular adenoma, focal nodular hyperplasia, cirrhosis and hepatocellular carcinoma. Histopathology 1995;26:63-68
14. Okuda K: Hepatocellular carcinoma: Recent progress. Hepa-tology 1992;15:948-963
15. Pezzella F, Tse AGD, Cordell JL, Pulford KAF, Gatter KC, Mason DY: Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation. Am J Pathol 1990;13:225-232
16. Pezzella F, Turley H, Kuzu I, Tungekar MF, Dunnill MS, Pierce GB, Harris A, Gatter KC, Mason DY: bcl-2 Protein in non-small-cell lung carcinoma. N Engl J Med 1993;329:690-724
17. Sakamoto M, Hirohashi S, Shimosato Y: Early stages of multistep hepatocarcinogenesis: Adenomatous hyperplasia and early hepatocellular carcinoma. Hum Pathol 1991;22:172-178
18. Schwarz LM, Smith SW, Jones HEE, Osborne BA: Do all programmed cell deaths occur via apoptosis? Proc Natl Acad Sci USA 1993; 90:980-984
19. Tao LC: Liver and Pancreas. In Comprehensive Cytopathol-ogy. Edited by M Bibbo. Philadelphia, WB Saunders, 1991, pp 822-829
20. Tao LC, Ho CS, McLoughlin MJ, Evans WK, Donat EE: Cytologic diagnosis of hepatocellular carcinoma by fine-needle aspiration biopsy. Cancer 1984;53:547-552
21. Tarao K, Ohkawa S, Shimizu A, Harada M, Nakamura Y, Okamoto N, Ito Y, Tamai S, Limori K, Sugimasa Y, Takemiya S, Okamoto T, Inoue T, Kanisawa M: DNA synthesis activities of hepatocytes from noncancerous cirrhotic tissue and of hepatocellular carcinoma (HCC) cells from cancerous tissue can predict the survival of hepatectomized patients with HCC. Cancer 1993;71:3859-3863
22. Troncone G, Zeppa P, Vetrani A, D'arcangelo A, Fulciniti F, De Divitiis B, Palombini L: bcl-2 Protein in breast cancer cells obtained by fine-needle aspiration (FNA): A preliminary report. Cytopathology 1995;6:219-225
23. Tsuda H, Zhang W, Shimosato Y, Yokota Y, Terada M, Sug-imura T, Miyamura T: Allele loss on chromosome 16 associates with progression of human hepatocellular carcinoma. Proc Natl Acad Sci USA 1990;87:6791-6794
24. Tusujimoto V, Croce C: Analysis of the structure, transcripts and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc Natl Acad Sci USA 1986;83:5214-5218
25. Vaux DL: Toward an understanding of the molecular mechanisms of physiological cell death. Proc Natl Acad Sci USA 1993;90:786-789
26. Vaux DL, Cory S, Adams J: bcl-2 Gene promotes hematopoietic cell survival and cooperates with c-myc to immortalize pre-V-cells. Nature 1988;335:440-442
27. Williams GT: Molecular regulation of apoptosis: Genetic controls on cell death. Cell 1993;74:777-779
28. Williams GT: Programmed cell death: Apoptosis and oncogenesis. Cell 1991;65:1087-1088
29. Zeppa P, Vetrani A, Palombini L, Chiacchio R, Zabatta A, De Sio I, Castellano L, Calandra M, Fulciniti F, De Rosa G: Evolution of DNA content in small and well-differentiated hepatocarcinoma. Analyt Quant Cytol Histol 1993;15:12-22
30. Zhao M, Zhang NX, Economou M, Blama I, Laissue JA, Zimmermann A: Immunohistochemical detection of bcl-2 protein in liver lesions: bcl-2 Protein is expressed in hepatocellular carcinomas but not in liver cell dysplasia. Histopathol 1994;25:233-245